low
2025-10-28
BGI's Gene Sequencing Patent Licensed Overseas, Securing $120 Million
狂揽1.2亿美金！首个基因测序专利出海，来自华大智造
This document reports that BGI's subsidiary has licensed its 'CoolMPS' gene sequencing technology patents and related intellectual property to a Swiss biotech company for development and commercialization in markets outside Asia-Pacific and Greater China, generating $120 million in revenue.
Document Text
237 characters
10月28日，深圳华大智造科技股份有限公司（以下简称“华大智造”）宣布将通过美国子公司MGI US LLC及Complete Genomics,Inc.，与瑞士生物科技企业Swiss Rockets AG（简称“Swiss Rockets”）达成技术授权合作。华大智造将一项名为“CoolMPS”的测序技术相关专利、商标、专有技术和软件以独占许可/普通许可的方式授权予Swiss Rockets，用于在除亚太及大中华区以外的全球市场进行开发、生产及商业化。<br>
合作达成现场
Topics
biotechnology
intellectual property
overseas investment
Metadata
| Publisher | |
| Site | sz_invest |
| Date | 2025-10-28 |
| Category | other |
| Policy Area | 海外投资案例 |
| CMS Category | 海外投资实际案例 |